[1] |
Kaushik N, Pujalte GG, Reese ST. Superficial fungal infections[J]. Prim Care Clin Office Pract, 2015,42(4):501⁃516. doi:10. 1016/j.pop.2015.08.004.
|
[2] |
中国体癣和股癣诊疗指南工作组. 中国体癣和股癣诊疗指南(2018修订版)[J]. 中国真菌学杂志, 2019,14(1):1⁃3.
|
[3] |
Hawkins DM, Smidt AC. Superficial fungal infections in children[J]. Pediatr Clin N Am, 2014,61(2):443⁃455. doi:10.1016/j.pcl. 2013.12.003.
|
[4] |
Gupta AK, Mays RR, Versteeg SG, et al. Onychomycosis in children: safety and efficacy of antifungal agents[J]. Pediatr Dermatol, 2018,35(5):552⁃559. doi: 10.1111/pde.13561.
|
[5] |
Ameen M, Lear JT, Madan V, et al. British Association of Dermatologists′ guidelines for the management of onychomycosis 2014[J]. Br J Dermatol, 2014,171(5):937⁃958. doi: 10.1111/bjd.13358.
|
[6] |
Chen X, Jiang X, Yang M, et al. Systemic antifungal therapy for tinea capitis in children: an abridged Cochrane review[J]. J Am Acad Dermatol, 2017,76(2):368⁃374. doi: 10.1016/j.jaad. 2016.08.061.
|
[7] |
中国头癣诊疗指南工作组. 中国头癣诊断和治疗指南(2018修订版)[J]. 中国真菌学杂志, 2019,14(1):4⁃6.
|
[8] |
中华医学会皮肤性病学分会, 中国中西医结合学会皮肤性病专业委员会, 中国医师协会皮肤科医师分会. 中国甲真菌病诊疗指南(2015年版)[J]. 中国真菌学杂志, 2019,10(2):118⁃125. doi: 10.3969/j.issn.1673⁃3827.2015.02.018.
|
[9] |
Kaul S, Yadav S, Dogra S. Treatment of dermatophytosis in elderly, children, and pregnant women[J]. Indian Dermatol Online J, 2017,8(5):310⁃318. doi: 10.4103/idoj.IDOJ_169_17.
|
[10] |
Gupta AK, Foley KA. Antifungal treatment for pityriasis versicolor[J]. J Fungi (Basel), 2015,1(1):13⁃29. doi: 10.3390/jof1010013.
|
[11] |
Ramírez SMC. Sporotrichosis: the story of an endemic region in Peru over 28 years (1985 to 2012)[J/OL]. PLoS One, 2015,10(6):e0127924. doi: 10.1371/journal.pone.0127924.
|
[12] |
Song Y, Li SS, Zhong SX, et al. Report of 457 sporotrichosis cases from Jilin province, northeast China, a serious endemic region[J]. J Eur Acad Dermatol Venereol, 2013,27(3):313⁃318. doi: 10.1111/j.1468⁃3083.2011.04389.x.
|
[13] |
中华医学会皮肤性病学分会真菌学组, 中国医师协会皮肤科医师分会医学真菌亚专业委员会, 中西医结合学会皮肤性病专业委员会真菌学组.孢子丝菌病诊疗指南[J]. 中华皮肤科杂志, 2016,49(7):456⁃459. doi:10.3760/cma.j.issn.0412⁃4030. 2016.07.002.
|
[14] |
Kauffman CA, Bustamante B, Chapman SW, et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2007,45(10):1255⁃1265. doi: 10.1086/522765.
|
[15] |
Groll AH, Tragiannidis A. Recent advances in antifungal prevention and treatment[J]. Semin Hematol, 2009,46(3):212⁃229. doi: 10.1053/j.seminhematol.2009.03.003.
|
[16] |
Hani U, Shivakumar HG, Vaghela R, et al. Candidiasis: a fungal infection⁃⁃current challenges and progress in prevention and treatment[J]. Infect Disord Drug Targets, 2015,15(1):42⁃52. doi: 10.2174/1871526515666150320162036.
|
[17] |
Puia⁃Dumitrescu M, Smith PB. Antifungal drugs in newborns and children[J]. Pediatr Clin North Am, 2017,64(6):1389⁃1402. doi: 10.1016/j.pcl.2017.08.013.
|
[18] |
Tragiannidis A, Tsoulas C, Groll AH. Invasive candidiasis and candidaemia in neonates and children: update on current guidelines[J]. Mycoses, 2015,58(1):10⁃21. doi: 10.1111/myc. 12268.
|
[19] |
Mantadakis E, Pana ZD, Zaoutis T. Candidemia in children: Epidemiology, prevention and management[J]. Mycoses, 2018,61(9):614⁃622. doi: 10.1111/myc.12792.
|
[20] |
Loo DS. Onychomycosis in the elderly : drug treatment options[J]. Drugs Aging, 2007,24(4):293⁃302. doi: 10.2165/00002512⁃200724040⁃00003.
|
[21] |
Gupta AK, Lane D, Paquet M. Systematic review of systemic treatments for tinea versicolor and evidence⁃based dosing regimen recommendations[J]. J Cutan Med Surg, 2014,18(2):79⁃90. doi: 10.2310/7750.2013.13062.
|
[22] |
Macedo PM, Lopes⁃Bezerra LM, Bernardes⁃Engemann AR, et al. New posology of potassium iodide for the treatment of cutaneous sporotrichosis: study of efficacy and safety in 102 patients[J]. J Eur Acad Dermatol Venereol, 2015,29(4):719⁃724. doi: 10.1111/ jdv.12667.
|
[23] |
Orofino⁃Costa R, Macedo PM, Rodrigues AM, et al. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics[J]. An Bras Dermatol, 2017,92(5):606⁃620. doi: 10.1590/abd1806⁃4841.2017279.
|
[24] |
Pappas PG, Kauffman CA, Andes DR, et al. Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016,62(4):409⁃417. doi: 10.1093/cid/civ1194.
|
[25] |
Cuenca⁃Estrella M, Verweij PE, Arendrup MC, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures[J]. Clin Microbiol Infect, 2012,18 Suppl 7:9⁃18. doi: 10.1111/1469⁃0691.12038.
|
[26] |
Brüggemann RJ, Alffenaar JW, Blijlevens NM, et al. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents[J]. Clin Infect Dis, 2009,48(10):1441⁃1458. doi: 10.1086/598327.
|
[27] |
Macedo PM, Lopes⁃Bezerra LM, Bernardes⁃Engemann AR, et al. New posology of potassium iodide for the treatment of cutaneous sporotrichosis: study of efficacy and safety in 102 patients[J]. J Eur Acad Dermatol Venereol, 2015,29(4):719⁃724. doi: 10.1111/ jdv.12667.
|
[28] |
Stockton DL, Paller AS. Drug administration to the pregnant or lactating woman: a reference guide for dermatologists[J]. J Am Acad Dermatol, 1990,23(1):87⁃103. doi: 10.1016/0190⁃9622(90)70192⁃k.
|
[29] |
Patel VM, Schwartz RA, Lambert WC. Topical antiviral and antifungal medications in pregnancy: a review of safety profiles[J]. J Eur Acad Dermatol Venereol, 2017,31(9):1440⁃1446. doi: 10.1111/jdv.14297.
|
[30] |
Pilmis B, Jullien V, Sobel J, et al. Antifungal drugs during pregnancy: an updated review[J]. J Antimicrob Chemother, 2015,70(1):14⁃22. doi: 10.1093/jac/dku355.
|
[31] |
Cottreau JM, Barr VO. A review of antiviral and antifungal use and safety during pregnancy[J]. Pharmacotherapy, 2016,36(6):668⁃678. doi: 10.1002/phar.1764.
|
[32] |
Workowski KA. Centers for disease control and prevention sexually transmitted diseases treatment guidelines[J]. Clin Infect Dis, 2015,61 *(Suppl 8):S759⁃S762. doi: 10.1093/cid/civ771.
|
[33] |
Howley MM, Carter TC, Browne ML, et al. Fluconazole use and birth defects in the national birth defects prevention study[J]. Am J Obstet Gynecol, 2016,214(5):657.e1⁃9. doi: 10.1016/j.ajog. 2015.11.022.
|
[34] |
Barros MB, Schubach Ade O, do Valle AC, et al. Cat⁃transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis, 2004,38(4):529⁃535. doi: 10. 1086/381200.
|
[35] |
Fichman V, ACFD V, de Macedo PM, et al. Cryosurgery for the treatment of cutaneous sporotrichosis in four pregnant women[J/OL]. PLoS Negl Trop Dis, 2018,12(4):e0006434. doi: 10.1371/journal.pntd.0006434.
|
[36] |
Mahajan VK. Sporotrichosis: an overview and therapeutic options[J]. Dermatol Res Pract, 2014,2014:272376. doi: 10.1155/2014/272376.
|
[37] |
Carswell F, Kerr MM, Hutchison JH. Congenital goitre and hypothyroidism produced by maternal ingestion of iodides[J]. Lancet, 1970,1(7659):1241⁃1243. doi: 10.1016/s0140⁃6736(70) 91736⁃8.
|
[38] |
Kyriakidis I, Tragiannidis A, Munchen S, et al. Clinical hepatotoxicity associated with antifungal agents[J]. Expert Opin Drug Saf, 2017,16(2):149⁃165. doi: 10.1080/14740338.2017. 1270264.
|
[39] |
Khoza S, Moyo I, Ncube D. Comparative hepatotoxicity of fluconazole, ketoconazole, itraconazole, terbinafine, and griseofulvin in rats[J]. J Toxicol, 2017,2017:6746989. doi: 10.1155/2017/6746989.
|
[40] |
Chen SC, Slavin MA, Sorrell TC. Echinocandin antifungal drugs in fungal infections: a comparison [published correction appears in Drugs. 2011 Jan 22;71(2):253][J]. Drugs, 2011,71(1):11⁃41. doi:10.2165/11585270⁃000000000⁃00000
|
[41] |
Spernovasilis N, Kofteridis DP. Pre⁃existing liver disease and toxicity of antifungals[J]. J Fungi (Basel), 2018,4(4). doi: 10.3390/jof4040133.
|